News
-
Overlooked Cells Linked to Poor Outcomes in Breast Cancer
A little-studied group of cancer cells circulating in the bloodstream may play a bigger role in breast cancer progression than previously thought, according to new research published in Science Translational Medicine that sheds light on how the disease spreads and why some patients fare worse than others.
-
Transcription Factors Form Continuous ‘Circuit’ That Regulates T-cell Exhaustion
Scientists have discovered how two transcription factors form a reciprocal regulatory circuit that controls T-cell exhaustion and migration during viral infection, which may inform future therapeutic strategies for managing infections and cancer, according to a recent Northwestern Medicine study.
-
Policy Intervention Linked to Increase in Kidney Transplants in Black Patients
A national policy intervention implemented to address transplant inequities caused by race-based kidney function equations was associated with an increase in organ transplant rates among Black patients, according to a recent study published in JAMA Internal Medicine.
-
Uncovering a Genetic Driver of Rare Early-Onset Dementia
A global team of scientists has uncovered a new genetic risk factor for a rare and aggressive form of early-onset dementia, according to a study published in Nature Genetics.
-
Uncovering Cellular Drivers of Increased Brain Signal Activity
Northwestern Medicine scientists have discovered new insights into how high gamma activity, a widely studied brain signal, is generated, findings that can impact how past and future neurological studies using this signal are interpreted, according to a recent study published in Nature.
-
Imagination is More Than Sensory Replay
A new Northwestern University study suggests that higher‑level brain systems that interpret and organize perception may play a central role in imagination in addition to sensory systems.
Media Coverage
-
WGN
–
Dr. Elliott: Insulin, Liver Supplements, and More
Dr. Sterling Elliott, clinical pharmacist at Northwestern Medicine and assistant professor of orthopaedics at Feinberg School of Medicine, joins Lisa Dent to discuss some of the latest health headlines. He shares why certain drugs have seen dramatic price increases and shares ways that the prices can be brought down. He also discusses the effectiveness of…
-
NBC News
–
What’s Your Biological Age? Experts Explain the Benefits and Risks of At-Home Tests
Your chronological age, which measures how many years have passed since you were born, may not match your biological age, which reflects wear and tear on your body at a cellular level. Based on factors including genetics, lifestyle habits and medical history, you may be biologically older or younger than your chronological age. That’s because…
-
WGN
–
Dr. Santina Wheat On April’s Health Spotlight
Dr. Santina Wheat, Program Director, McGaw Northwestern Family Medicine Residency at Northwestern Medicine Delnor Hospital, joins Wendy Snyder for this week’s health update. Wendy and Dr. Wheat highlight several key health observances recognized during the month of April, starting with Parkinson’s Awareness, leading into Alcohol Awareness, and wrapping up with Stress Awareness.
-
The Associated Press
–
Can a Single Therapy Session Make a Difference? Experts Say Yes, With the Right Mindset
The therapy is what it sounds like: one session, typically an hour, where a counselor helps the client identify concrete steps toward relieving a specific problem. The intention is not to completely solve a problem, but rather to help clients walk away with a toolbox of strategies on how to approach it. It has become…
-
Scientific American
–
Why Do Black Women Have Worse IVF Outcomes?
For the past two decades, fertility specialists have wrestled with a troubling question: Why do Black people have lower live birth rates after in vitro fertilization (IVF) treatment than white people? Other promising areas of research include looking at aspects of the mental and physical health of the person trying to get pregnant, including their…
-
CNBC
–
FDA Approves Eli Lilly’s GLP-1 Pill, Opening the Next Phase of the Weight Loss Drug Market
The U.S. Food and Drug Administration has approved Eli Lilly’s GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight loss medications. In the U.S., Lilly will compete with Novo’s newly launched Wegovy pill. Where the two drugs are the same is the…
Events
Breakthroughs Podcast
Listen to the people behind the science. Our Breakthroughs Podcast series highlights the powerful collaborations and extraordinary discoveries happening at Feinberg.
Faculty and Awards
Student Awards
See how Feinberg students have been recognized for their extraordinary achievements in the clinic, laboratory and community. For more information, visit our Student Awards page.
About the News Center
Through the News Center, Northwestern University Feinberg School of Medicine highlights our many educational programs, innovative research and discoveries, and our outstanding students, faculty, and staff. The News Center also captures mentions of Feinberg people and work in external media outlets. Learn more about us.